HighVista Strategies »

Septerna shares owned by HighVista Strategies

Quarter-by-quarter ownership of Septerna (SEPN) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Septerna

Tip: Access up to 7 years of quarterly data

All positions including Septerna held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Septerna by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 79k 27.88

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Septerna

RA Capital Management
TRV GP V
Driehaus Capital Management
Trv Gp Vi
Samsara BioCapital
Goldman Sachs Group
Siren
BlackRock
Vanguard Group
BVF
venBio Select Advisor
Vanguard Capital Management
ADAR1 Capital Management
PRIMECAP Management Company
Henderson Group

View all funds holding Septerna